S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential
The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...
Yahoo Finance11d
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
In July 2024, Moderna was awarded $176 million from the US government to advance the development of its mRNA H5N1 (bird flu) vaccine, which is in the early stages of testing. The award came ...
Moderna Announces Updates on Pandemic Influenza Program
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
WBAL12h
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna Gets $590 Million in Federal Funding for Bird Flu Vaccine
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...